TI
AGIO icon

Trexquant Investment’s Agios Pharmaceuticals AGIO Stock Holding History

Trexquant Investment’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.47M Buy
93,539
+18,241
+24% +$553K 0.02% 935
2026
Q1 		$2.55M Sell
75,298
-151,302
-67% -$4.29M 0.02% 901
2025
Q4 		$6.17M Buy
+226,600
New +$7.95M 0.06% 498
2025
Q3 		– Sell
-98,401
Closed -$3.27M – 1554
2025
Q2 		$3.27M Buy
+98,401
New +$2.98M 0.04% 702
2025
Q1 		– Sell
-69,971
Closed -$2.3M – 1521
2024
Q4 		$2.3M Buy
69,971
+45,005
+180% +$2.11M 0.03% 811
2024
Q3 		$1.11M Sell
24,966
-130,110
-84% -$5.91M 0.01% 1017
2024
Q2 		$6.69M Buy
155,076
+94,387
+156% +$3.41M 0.1% 315
2024
Q1 		$1.77M Buy
60,689
+6,148
+11% +$165K 0.04% 697
2023
Q4 		$1.21M Buy
+54,541
New +$1.22M 0.03% 756
2023
Q2 		– Sell
-24,613
Closed -$565K – 1397
2023
Q1 		$565K Buy
+24,613
New +$654K 0.02% 946
2021
Q2 		– Sell
-6,894
Closed -$356K – 1051
2021
Q1 		$356K Buy
+6,894
New +$341K 0.03% 672
2020
Q4 		– Sell
-11,622
Closed -$407K – 982
2020
Q3 		$407K Buy
11,622
+1,885
+19% +$82.6K 0.03% 789
2020
Q2 		$521K Sell
9,737
-9,223
-49% -$427K 0.04% 667
2020
Q1 		$673K Buy
+18,960
New +$876K 0.05% 551
2019
Q3 		– Sell
-21,138
Closed -$1.05M – 836
2019
Q2 		$1.05M Buy
+21,138
New +$1.13M 0.09% 298
2019
Q1 		– Sell
-17,584
Closed -$811K – 959
2018
Q4 		$811K Buy
+17,584
New +$1.09M 0.05% 479
2018
Q1 		– Sell
-3,690
Closed -$211K – 1038
2017
Q4 		$211K Buy
+3,690
New +$232K 0.02% 913

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Trexquant Investment's AGIO Position: Q2 2026 in Review

Trexquant Investment increased its Agios Pharmaceuticals (AGIO) stake by 24% in Q2 2026, buying an estimated $553K and bringing the position to 93,539 shares worth $3.47M. The position accounts for 0.02% of the portfolio, ranked #935.

Trexquant Investment first reported a position in AGIO in Q4 2017 and has held it in 17 quarters since. The position peaked at $6.69M in Q2 2024. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Trexquant Investment held 93,539 shares of Agios Pharmaceuticals worth $3.47M as of Q2 2026.
  • Trexquant Investment bought 18,241 Agios Pharmaceuticals shares in Q2 2026, an estimated $553K.
  • Agios Pharmaceuticals made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #935 holding.
  • Trexquant Investment first reported a position in Agios Pharmaceuticals in Q4 2017 and has held it in 17 quarters since.
  • Trexquant Investment's Agios Pharmaceuticals position peaked at $6.69M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.